JP2007503841A5 - - Google Patents

Download PDF

Info

Publication number
JP2007503841A5
JP2007503841A5 JP2006526218A JP2006526218A JP2007503841A5 JP 2007503841 A5 JP2007503841 A5 JP 2007503841A5 JP 2006526218 A JP2006526218 A JP 2006526218A JP 2006526218 A JP2006526218 A JP 2006526218A JP 2007503841 A5 JP2007503841 A5 JP 2007503841A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006526218A
Other languages
Japanese (ja)
Other versions
JP2007503841A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/028970 external-priority patent/WO2005023987A2/en
Publication of JP2007503841A publication Critical patent/JP2007503841A/ja
Publication of JP2007503841A5 publication Critical patent/JP2007503841A5/ja
Pending legal-status Critical Current

Links

JP2006526218A 2003-09-03 2004-09-02 薬剤作用を決定するための細胞ベースのアッセイ法 Pending JP2007503841A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50018003P 2003-09-03 2003-09-03
PCT/US2004/028970 WO2005023987A2 (en) 2003-09-03 2004-09-02 Cell-based assays for determining drug action

Publications (2)

Publication Number Publication Date
JP2007503841A JP2007503841A (ja) 2007-03-01
JP2007503841A5 true JP2007503841A5 (enExample) 2007-12-06

Family

ID=34272923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526218A Pending JP2007503841A (ja) 2003-09-03 2004-09-02 薬剤作用を決定するための細胞ベースのアッセイ法

Country Status (6)

Country Link
US (1) US20070072246A1 (enExample)
EP (1) EP1668361A4 (enExample)
JP (1) JP2007503841A (enExample)
AU (1) AU2004271183A1 (enExample)
CA (1) CA2576406A1 (enExample)
WO (1) WO2005023987A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094992A2 (en) * 2003-04-23 2004-11-04 Bioseek, Inc. Methods for analysis of biological dataset profiles
EP1719051A4 (en) * 2004-02-27 2009-06-17 Bioseek Inc BIOLOGICAL RECORDING OF ASTHMA AND ATOPY
US20060141508A1 (en) * 2004-11-30 2006-06-29 Michelle Palmer Cellular signaling pathway based assays, reagents and kits
US9734282B2 (en) 2005-03-28 2017-08-15 Discoverx Corporation Biological dataset profiling of cardiovascular disease and cardiovascular inflammation
WO2008018905A2 (en) * 2006-01-17 2008-02-14 Cellumen, Inc. Method for predicting biological systems responses
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US20100009352A1 (en) * 2006-05-24 2010-01-14 Gough Albert H Method for Modeling a Disease
EP2023874A4 (en) 2006-06-02 2009-07-08 Bioseek Inc METHOD FOR IDENTIFYING ACTIVE SUBSTANCES AND THEIR USE FOR THE PREVENTION OF RESTENOSIS
US20100112602A1 (en) * 2006-11-10 2010-05-06 Taylor Lansing D Protein-Protein Interaction Biosensors and Methods of Use Thereof
US20100093613A1 (en) * 2007-03-09 2010-04-15 Kunkel Eric J Methods for identifying agents and their use for the prevention or stabilization of fibrosis
WO2008121896A2 (en) 2007-03-30 2008-10-09 Bioseek, Inc. Methods for classification of toxic agents and counteragents
US8536135B2 (en) * 2008-03-19 2013-09-17 Ontherix, Inc. Adaptive biochemical signatures
CA2718969A1 (en) * 2008-03-19 2009-09-24 Ontherix, Inc. Adaptive biochemical signatures
ES2739623T3 (es) 2011-03-17 2020-02-03 Cernostics Inc Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos
US20170363614A1 (en) * 2014-12-22 2017-12-21 Enumeral Biomedical Holdings, Inc. Methods For Screening Therapeutic Compounds
WO2016168565A1 (en) * 2015-04-16 2016-10-20 President And Fellows Of Harvard College Methods for treatment of chronic obstructive pulmonary disease and/or therapy monitoring
CN112466403B (zh) * 2020-12-31 2022-06-14 广州基迪奥生物科技有限公司 一种细胞通讯分析方法及系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4007401A (en) * 2000-03-06 2001-09-17 Bioseek Inc Function homology screening
US6763307B2 (en) * 2000-03-06 2004-07-13 Bioseek, Inc. Patient classification
US7266458B2 (en) * 2000-03-06 2007-09-04 Bioseek, Inc. BioMAP analysis
AU2002365904A1 (en) * 2001-07-10 2003-09-04 Gene Logic, Inc. Cardiotoxin molecular toxicology modeling
US7623969B2 (en) * 2002-01-31 2009-11-24 The Institute For Systems Biology Gene discovery for the system assignment of gene function
WO2003068054A2 (en) * 2002-02-13 2003-08-21 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Services Identification of ovarian cancer tumor markers and therapeutic targets
EP1620722A4 (en) * 2003-04-23 2008-01-30 Bioseek Inc METHODS FOR CHARACTERIZING SIGNALING PATHWAYS AND COMPOUNDS INTERACTING THEREWITH
WO2004094992A2 (en) * 2003-04-23 2004-11-04 Bioseek, Inc. Methods for analysis of biological dataset profiles

Similar Documents

Publication Publication Date Title
BE2024C508I2 (enExample)
BE2023C542I2 (enExample)
BE2020C513I2 (enExample)
BE2020C517I2 (enExample)
BE2019C540I2 (enExample)
BE2019C523I2 (enExample)
BE2019C548I2 (enExample)
BE2019C506I2 (enExample)
BE2020C525I2 (enExample)
BE2017C063I2 (enExample)
BE2017C027I2 (enExample)
BE2016C067I2 (enExample)
BE2015C041I2 (enExample)
BE2015C014I2 (enExample)
BE2015C015I2 (enExample)
BE2014C064I2 (enExample)
BE2014C063I2 (enExample)
BE2014C010I2 (enExample)
BE2013C071I2 (enExample)
BE2013C021I2 (enExample)
BE2015C066I2 (enExample)
BE2015C065I2 (enExample)
BE2019C535I2 (enExample)
BE2015C033I2 (enExample)
BE2015C012I2 (enExample)